Cargando…
Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy
PROPOSE: Pregnancy is a risk factor for severe COVID-19. Treatment with monoclonal antibodies has been shown to decrease the risk of progression to severe COVID-19, but there are few reports on treating pregnant women. Here, we describe the clinical outcome of seven hospitalized pregnant women treat...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046532/ https://www.ncbi.nlm.nih.gov/pubmed/35482208 http://dx.doi.org/10.1007/s15010-022-01829-4 |